Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:monoclonal_antibody |
| gptkbp:administeredBy |
intravenous infusion
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA 2013 |
| gptkbp:ATCCode |
L01XC33
|
| gptkbp:developedBy |
gptkb:Roche
|
| gptkbp:genericName |
gptkb:obinutuzumab
|
| https://www.w3.org/2000/01/rdf-schema#label |
Gazyvaro
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Gazyva
|
| gptkbp:mechanismOfAction |
induces apoptosis of B cells
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
infections
neutropenia thrombocytopenia infusion reactions |
| gptkbp:target |
gptkb:CD20
|
| gptkbp:usedFor |
chronic lymphocytic leukemia
follicular lymphoma |
| gptkbp:bfsParent |
gptkb:obinutuzumab
|
| gptkbp:bfsLayer |
8
|